NATIONAL POLICY ON CHEMOTHERAPY SAFETY (CHEMOSAFE)
Date
2021-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Federal Ministry of Health
Abstract
The Federal Ministry of Health is committed to making all forms of cancer treatment more accessible and affordable in Nigeria. This underscores the collaboration currently in place to increase access to quality cancer care services at markedly reduced cost across the country. The Ministry is also paying particular attention towards improving access to radiotherapy services as well as improved expertise for surgical interventions nationwide.
Description
Table of Contents........................................................................................................................i
List of Figures.......................................................................................................................... iii
List of Tables ............................................................................................................................iv
Foreword....................................................................................................................................v
Acknowledgement ...................................................................................................................vii
List of Contributors................................................................................................................ viii
Acronyms / Abbreviations........................................................................................................ix
1.0 BACKGROUND ............................................................................................................1
1.1 Introduction .................................................................................................................1
1.2 Rationale for ChemoSafe Policy.................................................................................2
1.3 Goal and Objectives....................................................................................................4
1.3.1 Goal...........................................................................................................................4
1.3.2 Objectives .................................................................................................................4
1.4 Scope of the Policy......................................................................................................4
1.5 Policy Development Process.......................................................................................5
1.6 Updating......................................................................................................................5
2.0 POLICY FRAMEWORK ELEMENTS / THEMATIC AREAS ...................................6
2.1 The Environment.........................................................................................................6
2.1.1 Segregation of Chemotherapy Administration Area............................................6
2.1.2 Infrastructure (safety cabinets and compounding equipment).............................6
2.2 Supply Chain...............................................................................................................9
2.2.1 Transportation......................................................................................................9
2.2.2 Receiving and storage of Chemotherapy .............................................................9
2.2.3 Handling – compounding and dispensing..........................................................10
2.2.4 Checks required before Chemotherapy Administration ....................................10
2.3 Patient Care ...............................................................................................................11
2.3.1 Patient safety......................................................................................................11
2.3.2 Sources of exposure to cytotoxic medicines on health workers........................11
2.3.3 Disposal of Drug Contaminated Materials ........................................................12
2.4 Practitioner’s Responsibilities...................................................................................12
2.4.1 Training and Information Dissemination...........................................................13
2.4.2 Recommended safety precautions for practitioners (Oncology Doctors, Pharmacist, Nurses, Assistants and Hygienists)...............................13
2.4.3 Pregnancy, nursing or planning to become pregnant................19
2.4.4 Employee Information..................................19
2.4.5. Record Keeping......................................19
2.5 Capacity Building..................................19
2.5.1 Employee Training...........................20
2.6 monotoring and Evaluation................... 20
2.7 funding.........................................................21
3.0 Annexures.............................................23
3.1 Definition of terms................................23
3.2 Essential Medicine list for cancers.................23
4.0 References.................................................28